Cargando…
A pilot study of cdc6 as a biomarker for circulating tumor cells in patients with lung cancer
BACKGROUND: Cell division cycle 6 (cdc6) is a key factor of DNA replication initiation license system and a proto‐oncogene. It has been detected in some tumor tissues to aid cancer diagnosis in many research projects. However, it remains unclear that if cdc6 could be detected in the peripheral blood...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307357/ https://www.ncbi.nlm.nih.gov/pubmed/32249466 http://dx.doi.org/10.1002/jcla.23245 |